NEW YORK (GenomeWeb News) – Invitrogen said today that it will become the exclusive North American distributor of all of MitoSciences products, which includes monoclonal antibodies and immunoassays for researching mitochondrial proteins and diseases.
 
Invitrogen said that as MitoSciences’ existing distribution agreements expire, it would take over those agreements worldwide on an exclusive basis. The firms did not disclose how many of those distribution agreements exist.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.